Metrovacesa SA

As of December 31, 2023, Metrovacesa SA carries a market capitalization of 1.22B, placing it among publicly traded companies globally. Its enterprise value stands at 1.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Metrovacesa SA's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2023, Metrovacesa SA has 151.51M shares outstanding.

These figures are as of December 31, 2023.

As of December 31, 2023, Metrovacesa SA maintains a current ratio of 3.85, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2023.

Over the twelve months ended December 31, 2023, Metrovacesa SA recorded an income tax benefit of -2.03M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, Metrovacesa SA's stock has declined approximately 0.19% over the past 52 weeks. The 50-day moving average sits at 10.44, while the 200-day moving average is 10.94.

As of December 31, 2023, Metrovacesa SA holds 124.52M in cash and equivalents against 438.39M in total debt, resulting in a net debt position of 366.06M. Total book value stands at 1.69B, with working capital of 1.58B providing operational flexibility.